Log In
Print
BCIQ
Print
Print this Print this
 

Oxtellar XR, oxcarbazepine (Epliga) (formerly SPN-804)

  Manage Alerts
Collapse Summary General Information
Company Supernus Pharmaceuticals Inc.
DescriptionOral, once-daily extended-release formulation of oxcarbazepine
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Latest Stage of DevelopmentMarketed
IndicationSeizures
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today